# Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia

> **NCT01588574** · PHASE2 · COMPLETED · sponsor: **Medy-Tox** · enrollment: 60 (actual)

## Conditions studied

- Cervical Dystonia

## Interventions

- **BIOLOGICAL:** MT10109
- **BIOLOGICAL:** BOTOX(Registered trade mark)

## Key facts

- **NCT ID:** NCT01588574
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-10
- **Final completion:** 2013-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01588574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01588574, "Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01588574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*